proprietary drug

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
Counterfeit Drug Influential Physician patent medicine Thought leader	Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, has announced that its raw material supplier has filed its response to questions relating to the Drug Master File (DMF) raised by the U. EURAND'S SUPPLIER SUBMITS RESPONSE TO FDA ON EUR-1008 by Worldwide Biotech Novar becomes MorphoSys' preferred collaborator for HuCAL-based drug discovery, alto MorphoSys to progress to the next stage of its corporate development, which invol a greater focus on drug discovery and development within the Novartis alliance, an proprietary drug development, thereby substantially reducing MorphoSys' reliance new or extended fee-for-service discovery deals. MorphoSys and Novartis forge strategic alliance by Pharma Tokyo, Japan, June 23, 2006 - (JCN) - Toyama Chemical has commenced phase I clinical trials of T-5224, its proprietary drug candidate for the treatment of rheumatoid arthritis (RA). Toyama Chemical Launches Phase I Clinical Trials of Anti-rheumatic ... by JCNN News Summaries	propiopromazine proplastid proplatelets Proplex T proplexus propofol propolis proportion proportional proportional gas detector proportional mortality proportionate mortality proposition propositus propoxur propoxycaine propoxyphene propoxyphene hydrochloride propoxyphene napsylate propoxyphene napsylate/propoxyphene HCl proppy propranolol propranolol HCl propranolol hydrochloride proprietary proprietary drug proprietary hospital proprietary medicine proprietary name proprietary product proprioception proprioceptive proprioceptive impulse proprioceptive influence proprioceptive mechanism proprioceptive neural facilitation proprioceptive neuromuscular facilitation proprioceptive receptor proprioceptive reflex proprioceptive sensation proprioceptor proprioceptor neuromuscular facilitation stretching proprioceptors proprotein proptometer proptosis Propulsid propulsion propyl propyl alcohol propylene	proprietaries proprietaries proprietaries proprietaries proprietaries proprietarily proprietarily proprietarily proprietarily proprietarily proprietary proprietary proprietary proprietary proprietary proprietary Proprietary Account of Introducing Brokers/Dealers proprietary article Proprietary Article Certificate Proprietary articles Proprietary Association of Great Britain Proprietary Change of Address Proprietary Closed Cell Resin Proprietary colonies proprietary colony proprietary colony Proprietary computer software Proprietary Data Protection Agreement Proprietary Debit Card Proprietary Debit Cards proprietary drug proprietary drugs proprietary drugs proprietary drugs proprietary drugs Proprietary Electronic Trading Systems Proprietary Electrophosphorescent Light Emitting Diode Proprietary fund Proprietary Funds proprietary hospital Proprietary Identifier eXtension Proprietary Information Proprietary Information Proprietary Information Proprietary Information Proprietary Information Proprietary Information Agreement Proprietary Information Disclosure Proprietary Information Exchange Agreement proprietary interest Proprietary Item Identification Listing proprietary lease Proprietary limited company proprietary matrix proprietary matrix proprietary matrix proprietary matrix proprietary medicine proprietary medicine proprietary medicine proprietary medicine

Mentioned in

References in periodicals archive

Medical browser

Full browser

Counterfeit Drug
Influential Physician
patent medicine
Thought leader

Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, has announced that its raw material supplier has filed its response to questions relating to the Drug Master File (DMF) raised by the U.

EURAND'S SUPPLIER SUBMITS RESPONSE TO FDA ON EUR-1008 by Worldwide Biotech

Novar becomes MorphoSys' preferred collaborator for HuCAL-based drug discovery, alto MorphoSys to progress to the next stage of its corporate development, which invol a greater focus on drug discovery and development within the Novartis alliance, an proprietary drug development, thereby substantially reducing MorphoSys' reliance new or extended fee-for-service discovery deals.

MorphoSys and Novartis forge strategic alliance by Pharma

Tokyo, Japan, June 23, 2006 - (JCN) - Toyama Chemical has commenced phase I clinical trials of T-5224, its proprietary drug candidate for the treatment of rheumatoid arthritis (RA).

Toyama Chemical Launches Phase I Clinical Trials of Anti-rheumatic ... by JCNN News Summaries

proportional gas detector

proportional mortality